Infopanel

Production Department

Taj Pharma India Ltd. is a state-of-the-art pharmaceutical manufacturing plant located in Sarigam, Gujarat, specializing in producing a wide range of pharmaceutical products. With a production capacity of 120 million tablets, 40 million capsules, 36,000 kg of dry blended powders/granules, 20 million effervescent tablets, 60 million oral jelly units, 40 million cream/ointment units, and 3 million oral sachets per month, Taj Pharma is equipped with advanced WHO-cGMP, GMP, GLP, EU-GMP, PICs, and ISO 9001:2018 certified facilities.

The production department is divided into several sections, each tailored for specific product types. These include tablets, capsules, dry blended powders, effervescent tablets, oral jelly, creams/ointments, and oral sachets. Each section is equipped with specialized machinery, such as tablet presses, capsule filling machines, granulation and blending systems, homogenizers, and packaging equipment, ensuring high-quality production and compliance with global pharmaceutical standards.

The plant’s infrastructure includes clean rooms for sterile and non-sterile production, a fully equipped analytical laboratory for product testing, a microbiology lab for ensuring product safety, and robust packaging and storage systems for raw materials and finished goods. Taj Pharma’s commitment to quality is reinforced by its stringent quality control and assurance systems, ensuring products meet all regulatory requirements.

By maintaining high standards of hygiene, efficiency, and regulatory compliance, Taj Pharma India Ltd. ensures the production of safe, high-quality pharmaceutical products. With continuous investment in modern equipment and skilled personnel, the plant delivers reliable, scalable manufacturing solutions to meet both domestic and international market demands.

Taj Pharma’s QC Department ensures the safety and quality of products through skilled personnel, specialized labs, and advanced testing equipment. It performs raw material, in-process, and finished product testing, follows strict SOPs, maintains thorough documentation, and complies with GMP and regulatory standards, ensuring consistent product excellence and compliance.

Personnel / Facilities: Taj Pharma’s QC department includes qualified chemists and microbiologists trained in GMP/GLP. It features chemical and microbiological labs, stability chambers, and clean rooms for testing raw materials, finished products, and sterile items.

Equipment / Standard Operating Procedures (SOPs): Taj Pharma’s QC department utilizes advanced equipment like HPLC, GC, UV-Vis spectrophotometers, and microbial testing tools. It follows detailed SOPs for testing, validation, and calibration, ensuring consistent quality and compliance.

Quality Control Testing / Quality Management System (QMS): Taj Pharma’s QC tests raw materials, in-process samples, and finished products for identity, potency, and safety. It follows a robust QMS with change control, CAPA, and microbiological testing to ensure compliance.

Documentation & Record-Keeping / Compliance with Regulatory Standards: Taj Pharma’s QC maintains thorough documentation for raw materials, testing, and batch release. It ensures compliance with GMP, FDA, EMA, and pharmacopoeial standards, ensuring product safety, efficacy, and regulatory adherence.

Risk Management & CAPA / Training & Personnel Development: Taj Pharma’s QC department ensures ongoing staff training on regulatory updates and new technologies. It uses LIMS for data automation, ensuring accurate, secure data management and maintaining compliance with industry standards.

QA Infrastructure & Facilities: QA infrastructure includes offices for documentation, deviation management, and product release, ensuring compliance, record-keeping, and batch certification.

Quality Systems & Procedures: Quality systems include SOPs, GMP compliance, batch record review, GDP, and internal audits to ensure accuracy, consistency, and regulatory adherence.

Quality Control (QC) Coordination & Validation & Qualification: QA ensures QC coordination through material testing, IPQC, and product testing while overseeing validation of processes, methods, cleaning, and equipment qualification.

Regulatory & Compliance Affairs / Stability & Product Monitoring: Regulatory affairs handle product filings, audits, pharmacovigilance, stability studies, and annual reviews to ensure compliance and quality monitoring.

Risk Management & CAPA / Training & Personnel Development: Risk management involves deviation investigation, change control, risk assessment, while training programs and QA awareness promote continuous improvement and compliance.

Ensuring Excellence, Delivering Trust – Quality First, Always!

Taj Pharma’s Quality Assurance (QA) Department plays a crucial role in ensuring the highest standards of quality, safety, and compliance in pharmaceutical manufacturing. The QA infrastructure includes a documentation room for maintaining essential records, a change control and deviation management area for handling process deviations, and a product release section to ensure batch compliance before market release.

The company follows stringent quality systems and procedures, including comprehensive Standard Operating Procedures (SOPs), adherence to Good Manufacturing Practices (GMP), and rigorous Batch Manufacturing and Packaging Record (BMR/BPR) reviews. Additionally, Good Documentation Practices (GDP) ensure traceable and accurate records, while regular internal audits maintain continuous improvement.

Taj Pharma coordinates closely with the Quality Control (QC) team to ensure all raw materials and finished products meet strict quality criteria. In-Process Quality Control (IPQC) monitors critical process parameters, while finished product testing ensures compliance with pharmacopeial standards.

The company employs robust validation and qualification protocols for processes, analytical methods, and equipment, ensuring manufacturing consistency and product quality. Regulatory and compliance affairs are managed by a dedicated team to handle regulatory filings and audits from global authorities such as the FDA and WHO, as well as pharmacovigilance to monitor adverse drug reactions.

With a strong focus on risk management and Corrective and Preventive Actions (CAPA), Taj Pharma continuously assesses and mitigates potential risks to product quality. The company also prioritizes training programs to ensure personnel are well-equipped with the latest GMP standards and industry knowledge.

Taj Pharma’s QA department ensures regulatory compliance and product excellence, reinforcing the company’s commitment to producing safe, effective, and high-quality pharmaceutical